TheEdgeResearch
Home / Stocks / VDQSF

Gnomestar Craft Inc. (VDQSF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.01 ▲ +733.33%
Market Cap
$5.3M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
3.72
52-Wk Range
0.000001-0.01
CEO
Mark Lotz BBA, CA,
Country
CA
Currency
USD

Gnomestar Craft Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Delta, BC, CA. The stock last traded at $0.01, up 733.33% on the session, giving a market capitalisation of $5.3M. On trailing twelve-month figures it carries a trailing P/E of -1.29, a net margin of -328.5%. Its beta of 3.72 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-1.29
Price / Sales
27.86
Price / Book
-0.68
EV / EBITDA
-16.74
Gross margin
-101.5%
Operating margin
-329.1%
Net margin
-328.5%
Return on equity
—
Debt / equity
-0.57
Current ratio
0.14
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2015-02-13
Headquarters
Delta, BC, CA
About Gnomestar Craft Inc.

Gnomestar Craft Inc. operates within the Canadian market, focusing on the cultivation and supply of both medical and adult-use cannabis products. Established in 2011, the company was previously known as Vodis Pharmaceuticals Inc. before officially adopting the name Gnomestar Craft Inc. in December 2020. Its primary operations are based in Delta, Canada.

Comparable companies

Gnomestar Craft Inc. is most often compared with the following Healthcare names:

GBHPFGLDFFNSPDFRSSFFTLRY.TOVRTHF
More research on VDQSF
VDQSF technical analysis VDQSF TheEdge Score Compare against peers
Open full interactive analysis & DCF →